Skip to content

Drug interactions

Quizartinib + Ribociclib

Severity: Major

Quizartinib and Ribociclib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs prolong the QT interval, and combined use raises the risk of torsades de pointes and sudden cardiac death. Ribociclib also inhibits CYP3A4, which may increase quizartinib exposure.

What this interaction means in plain words

Quizartinib and Ribociclib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Quizartinib belongs to Oncology; Ribociclib belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive QTc prolongation, with CYP3A4 inhibition raising quizartinib levels.

What to do

Avoid if possible; otherwise monitor ECG frequently, correct potassium and magnesium, and reduce the quizartinib dose per labeling for CYP3A inhibitors.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Quizartinib and Ribociclib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Quizartinib with Ribociclib?

MediHelp rates the interaction as major. Quizartinib and Ribociclib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs prolong the QT interval, and combined use raises the risk of torsades de pointes and sudden cardiac death. Ribociclib also inhibits CYP3A4, which may increase quizartinib exposure.

How serious is the interaction between Quizartinib and Ribociclib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if possible; otherwise monitor ECG frequently, correct potassium and magnesium, and reduce the quizartinib dose per labeling for CYP3A inhibitors.

What other medicines interact with Ribociclib?

MediHelp also lists interactions of Ribociclib with, for example, Amiodarone, Cisapride, Dofetilide. The full list is on the Ribociclib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in